Citation

DeSelm L, Huck B, Lan R, Neagu C, Potnick J, Xiao Y, Chen X, Jones R, Richardson TE, Heasley BH, Haxell T, Moore J, Tian H, Georgi K, Rohdich F, Sutton A, Johnson T, Mochalkin I, Jackson J, Lin J, Crowley L, Machl A, Clark A, Wilker E, Sherer B, Goutopoulos A.: Identification of Clinical Candidate M2698, a Dual p70S6K and Akt Inhibitor, for Treatment of PAM Pathway-Altered Cancers. J Med Chem, Volume 64 (19), 2021

Authors

Chen X, Clark A, Crowley L, DeSelm L, Georgi K, Goutopoulos A., Haxell T, Heasley BH, Huck B, Jackson J, Johnson T, Jones R, Lan R, Lin J, Machl A, Mochalkin I, Moore J, Neagu C, Potnick J, Richardson TE, Rohdich F, Sherer B, Sutton A, Tian H, Wilker E, Xiao Y

Journal

J Med Chem

Year

2021

DOI

10.1021/acs.jmedchem.1c01087

PubMed

34596404

Machine-readable

REST APIRDF